Immunosuppressive Agents and Bone Disease in Renal Transplant Patients With Hypercalcemia

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

Shaul G. Massry, Jack W. Coburn, Glenn M. Chertow et al. · Data Archiving and Networked Services (DANS) · 2003 · 2.5K citations

Medicine, Nephrology, Orthopedic Surgery +16

One Year of Alendronate after One Year of Parathyroid Hormone (1–84) for Osteoporosis

Dennis M. Black, John P. Bilezikian, Kristine E. Ensrud et al. · New England Journal of Medicine · 2005 · 608 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Cyclosporin-A<i>in Vivo</i>Produces Severe Osteopenia in the Rat: Effect of Dose and Duration of Administration*

Colin Movsowitz, Sol Epstein, M D Fallon et al. · Endocrinology · 1988 · 410 citations

Medicine, Endocrinology, Pharmacology +17

European Best Practice Guidelines for Renal Transplantation (Part 2).

F. Berthoux, Daniel Abramovicz, Henrik Ekberg et al. · Lund University Publications (Lund University) · 2002 · 372 citations

Medicine, Nephrology, Surgery +16

Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides

Randall E. Morris · Transplantation Reviews · 1992 · 257 citations

Medicine, Medicinal Chemistry, Pharmacology +12